Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Cash from Operations (2016 - 2025)

Surgery Partners' Cash from Operations history spans 12 years, with the latest figure at 103400000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 7.18% year-over-year to 103400000.0; the TTM value through Dec 2025 reached 274300000.0, down 8.6%, while the annual FY2025 figure was 274300000.0, 8.6% down from the prior year.
  • Cash from Operations for Q4 2025 was 103400000.0 at Surgery Partners, up from 83600000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 111400000.0 in Q4 2024 and bottomed at 2300000.0 in Q2 2021.
  • The 5-year median for Cash from Operations is 57350000.0 (2023), against an average of 55705000.0.
  • The largest annual shift saw Cash from Operations crashed 98.74% in 2021 before it skyrocketed 1730.43% in 2022.
  • A 5-year view of Cash from Operations shows it stood at 19700000.0 in 2021, then tumbled by 63.45% to 7200000.0 in 2022, then surged by 769.44% to 62600000.0 in 2023, then skyrocketed by 77.96% to 111400000.0 in 2024, then decreased by 7.18% to 103400000.0 in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Cash from Operations are 103400000.0 (Q4 2025), 83600000.0 (Q3 2025), and 81300000.0 (Q2 2025).